News Detail
New Delhi, 14 Jan 2023: In a new development to the long pending dispute between Swiss pharma major Novartis and Hyderabad-based pharma firm Natco Pharma, a single bench of Delhi High Court has issued an order restraining Natco, its management and distributors from infringing the......
View Details
Source : Pharmabiz
Natco Pharma
Novartis
Ceritinib
IPAB
Zykadia
Related News
- Zydus gets warning as FDA highlights glass contamination concerns and others (12-09-2024)
- MPIDC allotted land to 36 industries in Medical Devices Park, investment of 1.8k crore (12-09-2024)
- DCC asks states and UTs to ensure implementation of revised Schedule M (12-09-2024)
- NPPA fixes retail price of 62 new drugs, extends CP of knee implants (12-09-2024)
- US FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals (12-09-2024)
- Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine (12-09-2024)
- DCGI suspends permission to Entod pharma's 'Presvu Eye Drops', company to challenge order in court (11-09-2024)
- Diagnostic kits for early detection of Alzheimer’s and cancer launched (11-09-2024)
- FDI equity inflow into pharma sector grows to $236 million in Q1FY25 (11-09-2024)
- Steroid Use Could Raise Diabetes Risk (11-09-2024)